Thus, these findings suggest that DACH1 could suppress the hepatocellular carcinoma growth through inhibition on Wnt signaling, which might be mediated by phosphorylation of GSK3β to suppress the activation of β-catenin. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.